Sen. Bill Cassidy (R-LA) (Bill Clark/CQ Roll Call via AP Images)
September 23, 2024 02:30 PM EDT
Pharma
Law

Sen. Cas­sidy ques­tions Lil­ly and Am­gen on 340B re­stric­tions on con­tract phar­ma­cies

Zachary Brennan

Senior Editor

As the fed­er­al gov­ern­ment is threat­en­ing John­son & John­son with fines re­lat­ed to its uni­lat­er­al al­ter­ations to the 340B drug dis­count pro­gram …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

Over a year af­ter FDA re­jec­tion, Bio­haven claims suc­cess in piv­otal mus­cle dis­ease study

Q&A: Bris­tol My­ers’ tech chief on the promis­es and per­ils of AI bio

As­traZeneca, Dai­ichi’s TROP2 drug miss­es over­all sur­vival goal in Phase 3 breast can­cer tri­al

UCB adds three more FDA ap­provals to la­bel for po­ten­tial block­buster Bimzelx

Telix buys ra­dio­phar­ma­cy net­work for $230M up front to ex­pand US ca­pac­i­ty 

sponsored

PD­Cs vs. AD­Cs: A New Fron­tier in Tar­get­ed Can­cer Ther­a­pies and the Po­ten­tial for De­vel­op­ment Part­ner­ships

A service from the Financial Times